Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
1.
J Allergy Clin Immunol Pract ; 2(1): 13-9; quiz 20, 2014.
Article in English | MEDLINE | ID: mdl-24565764

ABSTRACT

Advances in the understanding of various malignancies and chronic inflammatory diseases has led to the development of better treatment options for prolonging patient survival and minimizing morbidity. The recognition of "first-line" chemotherapy and monoclonal agents for these conditions has given more urgency to the need to re-administer these drugs in cases of drug hypersensitivity reactions. Therefore, in these cases, not only is desensitization considered when there is no alternative therapy available but also when alternative treatments are considered therapeutically inferior and/or more toxic. In this article, we describe the steps involved in the evaluation of these patients, factors to consider before making a decision to desensitize, the implementation of desensitization protocols, and the outcomes of such procedures.


Subject(s)
Antibodies, Monoclonal/administration & dosage , Antibodies, Monoclonal/adverse effects , Antineoplastic Agents/administration & dosage , Antineoplastic Agents/adverse effects , Desensitization, Immunologic/methods , Drug Hypersensitivity/prevention & control , Adult , Antibodies, Monoclonal/immunology , Antineoplastic Agents/immunology , Child , Desensitization, Immunologic/adverse effects , Drug Administration Routes , Drug Administration Schedule , Drug Hypersensitivity/diagnosis , Drug Hypersensitivity/immunology , Humans , Patient Selection , Predictive Value of Tests , Risk Factors , Severity of Illness Index , Skin Tests , Treatment Outcome
2.
Ann Allergy Asthma Immunol ; 109(5): 309-313.e1, 2012 Nov.
Article in English | MEDLINE | ID: mdl-23062384

ABSTRACT

BACKGROUND: Cow's milk allergy is the most common food allergy in childhood. Many children with IgE-mediated cow's milk allergy may tolerate baked milk products, but few data exist on predictors of outcomes of baked milk challenges. OBJECTIVE: To determine the relation of milk protein allergen specific IgE (sIgE) levels and skin prick test (SPT) wheal size with baked milk challenge outcomes. METHODS: A retrospective medical record review was conducted of 35 baked milk challenges. SPT results, sIgE levels, demographic characteristics, and food challenge results were analyzed. RESULTS: Thirty-five children underwent open challenges to baked milk and 29 (83%) passed. Of those who failed, 3 (50%) passed the initial clinic challenge but developed symptoms to ongoing exposure at home, days to months later. One child who ultimately failed at home required epinephrine. Compared with those who passed, children who failed were younger (median age, 8.9 and 3.7 years, respectively; P = .02). Children with a milk SPT wheal less than 12 mm were more than 90% likely to pass a baked milk challenge, and no child with a milk SPT wheal less than 7 mm failed a baked milk challenge. We were also able to establish more than 90% predictive values for passing baked milk challenges with a casein SPT wheal of 9 mm, a milk sIgE level of 1.0 kU/L, and a casein sIgE level of 0.9 kU/L. CONCLUSION: Most children allergic to cow's milk tolerated baked milk. Milk protein SPT wheal may be more reliable than sIgE level in predicting outcomes of baked milk challenges. It is important to be aware of the possibility of late reactions to ongoing baked milk exposure.


Subject(s)
Antibody Specificity , Cooking , Immunoglobulin E/physiology , Milk Hypersensitivity/diagnosis , Milk Hypersensitivity/immunology , Hot Temperature , Humans , Immunoglobulin E/biosynthesis , Predictive Value of Tests , Retrospective Studies , Skin Tests , Treatment Outcome
3.
Allergy Asthma Proc ; 33(3): 275-81, 2012.
Article in English | MEDLINE | ID: mdl-22584194

ABSTRACT

Previous studies suggest that children with egg allergy may be able to tolerate baked egg. Reliable predictors of a successful baked egg challenge are not well established. We examined egg white-specific IgE levels, skin-prick test (SPT) results, and age as predictors of baked egg oral food challenge (OFC) outcomes. We conducted a retrospective chart review of children, aged 2-18 years, receiving an egg white-specific IgE level, SPT, and OFC to baked egg from 2008 to 2010. Fifty-two oral baked egg challenges were conducted. Of the 52 challenges, 83% (n = 43) passed and 17% (n = 9) failed, including 2 having anaphylaxis. Median SPT wheal size was 12 mm (range, 0-35 mm) for passed challenges and 17 mm (range, 10-30 mm) for failed challenges (p = 0.091). The negative predictive value for passing the OFC was 100% (9 of 9) if SPT wheal size was <10 mm. Median egg white-specific IgE was 2.02 kU/L (range, <0.35-13.00 kU/L) for passed challenges and 1.52 kU/L (range, 0.51-6.10 kU/L) for failed challenges (p = 0.660). Receiver operating characteristic (ROC) curve analysis for SPT revealed an area under the curve (AUC) of 0.64. ROC curve analysis for egg white-specific IgE revealed an AUC of 0.63. There was no significant difference in age between patients who failed and those who passed (median = 8.8 years versus 7.0 years; p = 0.721). Based on our sample, SPT, egg white-specific IgE and age are not good predictors of passing a baked egg challenge. However, there was a trend for more predictability with SPT wheal size.


Subject(s)
Egg Hypersensitivity/diagnosis , Eggs/adverse effects , Immunoglobulin E/immunology , Skin Tests , Adolescent , Child , Child, Preschool , Egg Hypersensitivity/immunology , Female , Humans , Male , ROC Curve
4.
Pediatr Allergy Immunol ; 21(8): 1114-8, 2010 Dec.
Article in English | MEDLINE | ID: mdl-21073539

ABSTRACT

Sesame and coconut are emerging food allergens in the United States. We sought to examine whether children allergic to peanuts and tree nuts are at increased risk of having an allergy to sesame or coconut. We performed a retrospective chart review of children who underwent skin prick testing (SPT) to sesame and coconut and identified 191 children who underwent SPT to sesame and 40 to coconut. Sensitization to sesame was more likely in children with positive SPT to peanuts (odds ratio [OR] = 6.7, 95% confidence interval [CI] [2.7-16.8], p < 0.001) and tree nuts (OR = 10.5, 95% CI [4.0-27.7], p < 0.001). Children with histories of both peanut and tree nut reaction were more likely to have a history of sesame reaction (OR = 10.2, 95% CI [2.7-38.7], p < 0.001). Children with sensitization or allergy to peanuts or tree nuts were not more likely to be sensitized or allergic to coconut. In conclusion, children with peanut or tree nut sensitization were more likely to be sensitized to sesame but not coconut. Children with clinical histories of both peanut and tree nut allergy were more likely to be allergic to sesame.


Subject(s)
Cross Reactions/immunology , Nut Hypersensitivity/epidemiology , Nut Hypersensitivity/immunology , Peanut Hypersensitivity/epidemiology , Peanut Hypersensitivity/immunology , Adolescent , Adult , Child , Child, Preschool , Cocos/immunology , Female , Humans , Immunization , Infant , Male , Nut Hypersensitivity/diagnosis , Peanut Hypersensitivity/diagnosis , Retrospective Studies , Risk , Sesamum/immunology , Skin Tests , United States
5.
Ann Allergy Asthma Immunol ; 92(4): 426-32, 2004 Apr.
Article in English | MEDLINE | ID: mdl-15104194

ABSTRACT

BACKGROUND: Antibiotic desensitization is an option for patients with suspected IgE-mediated antibiotic allergy when no other alternative exists for treating life-threatening bacterial infections. However, there are limited data describing the outcomes of this procedure with newer, commonly used antibiotics. OBJECTIVE: To evaluate the safety and utility of antibiotic desensitization. METHODS: We retrospectively reviewed the medical records of all patients undergoing antibiotic desensitization in our institution between November 1996 and November 2001. RESULTS: There were a total of 57 desensitizations performed in 21 patients. The mean age of the patients was 22.8 years (range, 1.9-44.5 years) and 15 (71%) were female. Nineteen (90%) of the 21 patients had been diagnosed as having cystic fibrosis. In 33 (100%) of 33 desensitizations to unique antibiotics that occurred during the study period, the indication for desensitization was a history suggestive of an IgE-mediated reaction to the antibiotic and/or a positive skin test result to the antibiotic or a known cross-reactive antibiotic. Desensitizations were performed to 12 different antibiotics. Successful outcomes were achieved in 43 desensitizations (75%). Of the 11 cases (19%) that were terminated due to an allergic reaction, there were no fatalities, intubations, or other aggressive interventions besides the use of epinephrine, antihistamines, and corticosteroids. In 7 of 11 unsuccessful desensitizations, a non-IgE mechanism appeared to be responsible for the allergic reaction. CONCLUSIONS: Antibiotic desensitization is a useful option when treating patients with life-threatening infections who must receive antibiotics to which they have an IgE-mediated allergy. These data indicate that in most cases, patients with presumed IgE-mediated antibiotic allergy may safely receive antibiotics after desensitization.


Subject(s)
Anti-Bacterial Agents/immunology , Anti-Bacterial Agents/therapeutic use , Desensitization, Immunologic , Hypersensitivity, Immediate/immunology , Hypersensitivity, Immediate/therapy , Adolescent , Adult , Anti-Bacterial Agents/adverse effects , Antibody Specificity/drug effects , Antibody Specificity/immunology , Boston , Child , Child, Preschool , Cross Reactions/drug effects , Cross Reactions/immunology , Cystic Fibrosis/immunology , Cystic Fibrosis/therapy , Female , Humans , Immunoglobulin E/drug effects , Immunoglobulin E/immunology , Infant , Male , Retrospective Studies , Skin Tests , Treatment Outcome
6.
Pediatr Allergy Immunol ; 14(4): 307-11, 2003 Aug.
Article in English | MEDLINE | ID: mdl-12911510

ABSTRACT

The prevalence of food allergies is increasing. Concurrently, the average maternal age at birth is also increasing. We conducted a preliminary study to evaluate whether maternal age at the time of delivery is associated with a food allergy in children. Case and control patients were identified among consecutive patients seen by one of us (AD) in the Allergy/Immunology program at the Children's Hospital Boston between 11/1/98 and 2/28/00. Case patients were born in Massachusetts and had evidence of clinical sensitivity and IgE to one or more food allergens (n = 58). Control patients were those born in Massachusetts who had a negative skin test and/or RAST to inhalant and/or food allergens (n = 96). A second comparison group consisted of all live births in Massachusetts in 1999 (n = 80,866). Information on maternal age at birth was missing from 3/58 (5%) of patients with a food allergy and 4/96 (4%) of the control patients, so these patients were not included in the analysis. The proportion of children whose mother was aged 30 and over at their birth was significantly higher in children with a food allergy than control patients (78% vs. 55% p = 0.005) and higher than all births in Massachusetts (78% vs. 53% p = 0.0002). Mothers of children with a food allergy had about three times greater odds of being aged 30 or over at the time of delivery than mothers in either of the comparison groups. Further exploration of the data using logistic regression showed that maternal age over 30 at delivery and being first born were independent predictors of the child having a food allergy. In this study, the presence of a food allergy in children was related to older maternal age at delivery. Additional studies are needed to further evaluate this relationship and its potential implication in preventive strategies for food allergies in children.


Subject(s)
Delivery, Obstetric , Food Hypersensitivity/immunology , Maternal Age , Adult , Antibody Specificity/immunology , Case-Control Studies , Child , Child Welfare , Child, Preschool , Delivery, Obstetric/trends , Dermatitis, Atopic/epidemiology , Dermatitis, Atopic/immunology , Female , Food Hypersensitivity/epidemiology , Humans , Immunoglobulin E/immunology , Infant , Infant Welfare , Logistic Models , Male , Massachusetts/epidemiology , Odds Ratio , Risk Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...